Molecular Testing for EGFR Mutations: What Pathologists Need to Know

Lynette M. Sholl, MD, and Geoffrey R. Oxnard, MD, discuss EGFR mutation-positive lung cancer in this CME/MOC activity titled "Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and Updated Guidelines: What Pathologists Need to Know and Do." For the full presentation, downloadable practice aids and slides, complete CME/MOC information, and to apply for credit, please visit us at www.peerview.com/DZD865. CME/MOC credit will be available until February 10, 2020.